Pretreatment Neutrophil-to-Lymphocyte Ratio (NLR) May Predict the Outcomes of Advanced Non-small-cell Lung Cancer (NSCLC) Patients Treated With Immune Checkpoint Inhibitors (ICIs)

JOURNAL ARTICLE published 23 June 2020 in Frontiers in Oncology

Authors: Ye Li | Zhibo Zhang | Yi Hu | Xiang Yan | Qi Song | Guoqiang Wang | Runzhe Chen | Shunchang Jiao | Jinliang Wang